Dinaciclib, a Bimodal Agent Effective against Endometrial Cancer

SIMPLE SUMMARY: Endometrial cancer (EC) is diagnosed in almost 400,000 women every year globally and is the sixth most common cancer in women. When diagnosed early, treatment can result in a full recovery; however, when at an advanced stage, fewer than 50% of patients survive beyond 5 years and new...

Descripción completa

Detalles Bibliográficos
Autores principales: Howard, David, James, David, Murphy, Kate, Garcia-Parra, Jezabel, Pan-Castillo, Belen, Rex, Stuart, Moul, Annemarie, Jones, Eilir, Bilbao-Asensio, Marc, Michue-Seijas, Saul, Lutchman-Singh, Kerryn, Margarit, Lavinia, Francis, Lewis W., Rees, Paul, Gonzalez, Deyarina, Conlan, R. Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962054/
https://www.ncbi.nlm.nih.gov/pubmed/33800911
http://dx.doi.org/10.3390/cancers13051135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962054/
https://www.ncbi.nlm.nih.gov/pubmed/33800911
http://dx.doi.org/10.3390/cancers13051135

Ejemplares similares